William Cavanagh - Net Worth and Insider Trading

William Cavanagh Net Worth

The estimated net worth of William Cavanagh is at least $41,123 dollars as of 2024-05-24. William Cavanagh is the Chief R&D Officer of Perspective Therapeutics Inc and owns about 27,692 shares of Perspective Therapeutics Inc (CATX) stock worth over $41,123. Details can be seen in William Cavanagh's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William Cavanagh has not made any transactions after 2020-10-22 and currently still holds the listed stock(s).

Transaction Summary of William Cavanagh

To

William Cavanagh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William Cavanagh owns 1 companies in total, including Perspective Therapeutics Inc (CATX) .

Click here to see the complete history of William Cavanagh’s form 4 insider trades.

Insider Ownership Summary of William Cavanagh

Ticker Comapny Transaction Date Type of Owner
CATX Perspective Therapeutics Inc 2020-10-22 Vice President

William Cavanagh Latest Holdings Summary

William Cavanagh currently owns a total of 1 stock. William Cavanagh owns 27,692 shares of Perspective Therapeutics Inc (CATX) as of October 22, 2020, with a value of $41,123.

Latest Holdings of William Cavanagh

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CATX Perspective Therapeutics Inc 2020-10-22 27,692 1.49 41,123

Holding Weightings of William Cavanagh


William Cavanagh Form 4 Trading Tracker

According to the SEC Form 4 filings, William Cavanagh has made a total of 2 transactions in Perspective Therapeutics Inc (CATX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Perspective Therapeutics Inc is the acquisition of 7,692 shares on October 22, 2020, which cost William Cavanagh around $4,000.

Insider Trading History of William Cavanagh

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William Cavanagh Trading Performance

GuruFocus tracks the stock performance after each of William Cavanagh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Cavanagh is 309.77%. GuruFocus also compares William Cavanagh's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Cavanagh within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William Cavanagh's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William Cavanagh

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 23.68
Relative Return to S&P 500(%) 23.82

William Cavanagh Ownership Network

Ownership Network List of William Cavanagh

No Data

Ownership Network Relation of William Cavanagh


William Cavanagh Owned Company Details

What does Perspective Therapeutics Inc do?

Who are the key executives at Perspective Therapeutics Inc?

William Cavanagh is the Vice President of Perspective Therapeutics Inc. Other key executives at Perspective Therapeutics Inc include Chief Medical Officer Markus Puhlmann , Chief Financial Officer Jonathan Robert Hunt , and Vice President Lori A Woods .

Perspective Therapeutics Inc (CATX) Insider Trades Summary

Over the past 18 months, William Cavanagh made no insider transaction in Perspective Therapeutics Inc (CATX). Other recent insider transactions involving Perspective Therapeutics Inc (CATX) include a net purchase of 342,424 shares made by Williamson Robert F Iii , a net purchase of 875,425 shares made by Markus Puhlmann , and a net purchase of 210,404 shares made by Jonathan Robert Hunt .

In summary, during the past 3 months, insiders sold 0 shares of Perspective Therapeutics Inc (CATX) in total and bought 60,431,039 shares, with a net purchase of 60,431,039 shares. During the past 18 months, 0 shares of Perspective Therapeutics Inc (CATX) were sold and 62,044,492 shares were bought by its insiders, resulting in a net purchase of 62,044,492 shares.

Perspective Therapeutics Inc (CATX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Perspective Therapeutics Inc Insider Transactions

No Available Data

William Cavanagh Mailing Address

Above is the net worth, insider trading, and ownership report for William Cavanagh. You might contact William Cavanagh via mailing address: 350 Hills Street, Suite 106, Richland Wa 99354.

Discussions on William Cavanagh

No discussions yet.